Featured Products View All
High-Resolution Stability Characterization for Biologics — Now With DLSFeatured Product
NanoTemper TechnologiesREAD MORE
Malvern PanalyticalREAD MORE
Product News View All
AMSBIO is launching a new range of human iPSC-derived cells and human iPSC differentiation reagent kits optimized for high-throughput experiments in areas including drug discovery and toxicity screening.
AMSBIO announces StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells.
Antlia Bioscience, Inc., and XL-protein GmbH are pleased to announce a strategic slliance using XL-protein's proprietary PASylation® technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure.READ MORE
Iksuda Therapeutics Enters Agreement With University of Goettingen To Develop Novel Antibody Drug ConjugatesProduct News
Iksuda Therapeutics (Iksuda), today announces it has executed its option to secure exclusive, worldwide rights to develop a novel class of tumour-activated prodrug payloads from the University of Goettingen, following a successful collaboration exemplifying the series in ADC formats.READ MORE